Largest pharmaceuticals in France by market cap

ABIVAX has the lowest figure of the 2 pharmaceuticals in France ranked by market value, at $7.3B, followed by Sanofi ($113.9B). Figures as of 18 Nov 2026, 15:16 UTC, from Yahoo Finance quotes.

Only 2 companies have this figure here, too few to make a ranking, so this list is not offered to search engines.

Key facts

Companies ranked
2
Lowest
ABIVAX$7.3B
Combined market value
$121.2B
Countries
1

Market values as of .

Largest pharmaceuticals in France by market cap
#CompanyMarket cap ↑PriceToday1 yearPrice, 30 daysCountry
1ABIVAXABVX · Health Care$7.3B$83.90 2.19% up 27% down France
2SanofiSNY · Health Care$113.9B$47.44 0.20% down 4% down France

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration.

Questions and answers

Which pharmaceuticals in France have the lowest market cap?

ABIVAX ($7.3B) and Sanofi ($113.9B) have the lowest market cap of the 2 pharmaceuticals in France ranked here as of 18 Nov 2026, 15:16 UTC.

How many pharmaceuticals in France are in this ranking?

2 are ranked by market value.

What are these pharmaceuticals in France worth together?

The 2 pharmaceuticals in France ranked by market value have a combined market value of $121.2B as of 18 Nov 2026, 15:16 UTC.

What does ranking by market value measure?

What the stock market values the whole company at: its share price times the number of its shares.

Cite this page

Funkfolio, “Largest pharmaceuticals in France by market cap”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=france

Underlying data: Yahoo Finance; SEC EDGAR.